Impact of androgen deprivation therapy on depressive symptoms in men with nonmetastatic prostate cancer

Cancer

Volumn 118, Issue 7, 2012, Pages 1940-1945

  Timilshina, Narhari ^a   Breunis, Henriette ^a   Alibhai, Shabbir ^a,b,c,d  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b TORONTO REHABILITATION INSTITUTE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Androgen deprivation therapy; Depression; Geriatric depression scale; Prostate cancer

Indexed keywords

ADULT; AGE; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DETERIORATION; EDUCATION; GERIATRIC DEPRESSION SCALE; HUMAN; LINEAR REGRESSION ANALYSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; OUTCOME ASSESSMENT; PHYSICAL CAPACITY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; SCORING SYSTEM;

AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; CASE-CONTROL STUDIES; DEPRESSION; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS;

EID: 84858701258     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26477     Document Type: Article

References (36)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277-300.
2. Blazer DG. Depression in late life: review and commentary. J Gerontol A Biol Sci Med Sci. 2003;58:249-265. (Pubitemid 36307597)
3. Pirl WF. Evidence report on the occurrence, assessment, and treatment of depression in cancer patients. J Natl Cancer Inst Monogr. 2004:32-39.
4. Roth AJ, Kornblith AB, Batel-Copel L, Peabody E, Scher HI, Holland JC. Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study. Cancer. 1998;82:1904-1908. (Pubitemid 28208646)
5. Richardson JL, Shelton DR, Krailo M, Levine AM. The effect of compliance with treatment on survival among patients with hematologic malignancies. J Clin Oncol. 1990;8:356-364. (Pubitemid 20056570)
6. Herrmann C, Brand-Driehorst S, Kaminsky B, Leibing E, Staats H, Ruger U. Diagnostic groups and depressed mood as predictors of 22-month mortality in medical inpatients. Psychosom Med. 1998;60:570-577. (Pubitemid 28453020)
7. Spiegel D, Kato PM. Psychosocial influences on cancer incidence and progression. Harv Rev Psychiatry. 1996;4:10-26. (Pubitemid 26180723)
8. Meng MV, Grossfeld GD, Sadetsky N, Mehta SS, Lubeck DP, Carroll PR. Contemporary patterns of androgen deprivation therapy use for newly diagnosed prostate cancer. Urology. 2002;60(3 suppl 1):7-11; discussion 11-12.
9. Sharifi N, Gulley JL, Dahut WL. Androgen deprivation therapy for prostate cancer. JAMA. 2005;294:238-244. (Pubitemid 41043794)
10. Shahinian VB, Kuo YF, Freeman JL, Orihuela E, Goodwin JS. Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma. Cancer. 2005;103:1615-1624. (Pubitemid 40490022)
11. Alibhai SM, Gogov S, Allibhai Z. Long-term side effects of androgen deprivation therapy in men with non-metastatic prostate cancer: a systematic literature review. Crit Rev Oncol Hematol. 2006;60:201-215. (Pubitemid 44709617)
12. Alibhai SMH, Breunis H, Timilshina N, et al. Impact of androgen-deprivation therapy on physical function and quality of life in men with non-metastatic prostate cancer. J. Clin. Oncol. 2010;28:5038-5045.
13. Cherrier MM, Borghesani PR, Shelton AL, Higano CS. Changes in neuronal activation patterns in response to androgen deprivation therapy: a pilot study. BMC Cancer. 2010;10:1.
14. Nelson CJ, Lee JS, Gamboa MC, Roth AJ. Cognitive effects of hormone therapy in men with prostate cancer: a review. Cancer. 2008;113:1097-1106.
15. Sherwin BB. Steroid hormones and cognitive functioning in aging men: a mini-review. J Mol Neurosci. 2003;20:385-393. (Pubitemid 38146997)
16. Alibhai SMH, Breunis H, Timilshina N, et al. Impact of androgen-deprivation therapy on cognitive function in men with nonmetastatic prostate cancer. J Clin Oncol. 2010;38:5030-5037.
17. Mohile SG, Lacy M, Rodin M, et al. Cognitive effects of androgen deprivation therapy in an older cohort of men with prostate cancer. Crit Rev Oncol Hematol. 2010;75:152-159.
18. Gray RE, Wassersug RJ, Sinding C, Barbara AM, Trosztmer C, Fleshner N. The experiences of men receiving androgen deprivation treatment for prostate cancer: a qualitative study. Can J Urol. 2005;12:2755-2763.
19. Pirl WF, Greer JA, Goode M, Smith MR. Prospective study of depression and fatigue in men with advanced prostate cancer receiving hormone therapy. Psychooncology. 2008;17:148-153. (Pubitemid 351279865)
20. Pirl WF, Siegel GI, Goode MJ, Smith MR. Depression in men receiving androgen deprivation therapy for prostate cancer: a pilot study. Psychooncology. 2002;11:518-523. (Pubitemid 36007922)
21. Herr HW, O'Sullivan M. Quality of life of asymptomatic men with nonmetastatic prostate cancer on androgen deprivation therapy. J Urol. 2000;163:1743-1746. (Pubitemid 30366726)
22. Stone P, Hardy J, Huddart R, A'Hern R, Richards M. Fatigue in patients with prostate cancer receiving hormone therapy. Eur J Cancer. 2000;36:1134-1141. (Pubitemid 30330912)
23. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383. (Pubitemid 17055592)
24. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982;17:37-49. (Pubitemid 13123113)
25. Montorio I, Izal M. The geriatric depression scale: a review of its development and utiliy. Int Psychogeriatr. 1996;8:103-112. (Pubitemid 26248776)
26. Burke WJ, Roccaforte WH, Wengel SP. The short form of the Geriatric Depression Scale: a comparison with the 30-item form. J Geriatr Psychiatry Neurol. 1991;4:173-178.
27. Weintraub D, Saboe K, Stern MB. Effect of age on geriatric depression scale performance in Parkinson's disease. Mov Disord. 2007;22:1331-1335. (Pubitemid 47325045)
28. Chagas MH, Tumas V, Loureiro SR, et al. Validity of a Brazilian version of the Zung self-rating depression scale for screening of depression in patients with Parkinson's disease. Parkinsonism Relat Disord. 2010;16:42-45.
29. Mitchell AJ, Bird V, Rizzo M, Meader N. Diagnostic validity and added value of the Geriatric Depression Scale for depression in primary care: a meta-analysis of GDS30 and GDS15. J Affect Disord. 2010;125:10-17.
30. Wancata J, Alexandrowicz R, Marquart B, Weiss M, Friedrich F. The criterion validity of the Geriatric Depression Scale: a systematic review. Acta Psychiatr Scand. 2006;114:398-410. (Pubitemid 44707067)
31. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003;41:582-592.
32. Rosenblatt DE, Mellow A. Depression during hormonal treatment of prostate cancer. J Am Board Fam Pract. 1995;8:317-320.
33. Higano CS, Ellis W, Russell K, Lange PH. Intermittent androgen suppression with leuprolide and flutamide for prostate cancer: a pilot study. Urology. 1996;48:800-804. (Pubitemid 26409365)
34. Shahinian VB, Kuo YF, Freeman JL, Goodwin JS. Risk of the "androgen deprivation syndrome" in men receiving androgen deprivation for prostate cancer. Arch Intern Med. 2006;166:465-471.
35. Thompson CA, Shanafelt TD, Loprinzi CL. Andropause: symptom management for prostate cancer patients treated with hormonal ablation. Oncologist. 2003;8:474-487. (Pubitemid 37238876)
36. Rodin G, Lloyd N, Katz M, Green E, Mackay JA, Wong RK. The treatment of depression in cancer patients: a systematic review. Support Care Cancer. 2007;15:123-136. (Pubitemid 46332931)